About The Tribune-Review

The Tribune-Review can be reached via e-mail or at 412-321-6460.
Contact Us | Video | RSS | Mobile

Anette Duensing, 43, M.D. recently received funding from the GIST Cancer Research Fund — a patient-driven organization that funds research on gastrointestinal stromal tumors, or GISTs. This is the seventh year in a row that the research fund supports research in Duensing’s laboratory.

Daily Photo Galleries

Tuesday - June 18, 2013

Monday - June 17, 2013

Sunday - June 16, 2013

Dr. Anette Duensing

Noteworthy: Duensing received funding from the GIST Cancer Research Fund — a patient-driven organization that funds research on gastrointestinal stromal tumors, or GISTs. This is the seventh consecutive year that the fund has supported research in Duensing's laboratory.

Age: 43

Residence: O'Hara

Family: Husband, Stefan

Occupation: Assistant professor of pathology, University of Pittsburgh School of Medicine

Background: In 2000, during her postdoctoral fellowship at Brigham and Women's Hospital in Boston, Duensing experienced firsthand the tumor remission of the first GIST patient treated with the therapy drug Gleevec. Since then, her research has focused on a better molecular understanding of the biology of GISTs and the mode of action of Gleevec. Duensing joined the University of Pittsburgh Cancer Institute in 2003.

Education: Medical degree from the University of Hannover Medical School, Hannover, Germany, in 1997

Quote: “This generous funding has allowed us to significantly expand our efforts identifying novel treatment options for GIST patients — in particular for patients whose tumors have become resistant to Gleevec over time.”

— Chris Togneri

1. College teacher training found in study to be ‘industry of mediocrity’ harming educational system
2. Pittsburgh police, civilian employees to work convention
3. Delayed decision on drilling at parks risks losing Allegheny County millions, County Executive Fitzgerald says
4. Sewickley church can repurpose ‘pink house’ to fellowship center
5. Newsmaker: Jessica Vega-Rogowicz
6. Facial recognition technology moving toward identifying almost anyone
7. Small communication firms target system
8. Congressmen: VA Pittsburgh ignored requests for Legionnaires’ records
9. Sentencing postponed in Pitt online threats case
10. Civil War history hides in, around Pittsburgh
11. Newsmaker: Tom Lopus

Subscribe today! Click here for our subscription offers.